Company Filing History:
8 out of 11 
7 out of 4,770 
1 out of 2 Years Active: 1977-2016
Title: The Innovative Journey of David Penman Jacobus
Introduction
David Penman Jacobus, a prominent inventor based in Princeton, NJ, has made significant contributions to the field of pharmaceuticals with a strong focus on antimalarial compounds. With a remarkable portfolio of 16 patents, Jacobus continues to advance the fight against malaria, particularly the drug-resistant strains of the disease. His extensive work has positioned him as a key figure in pharmaceutical innovation.
Latest Patents
Among his latest innovations are two noteworthy patents:
1. **Heteroaryl derivatives and uses thereof** - This invention relates to antimalarial compounds and their application against protozoa of the genus Plasmodium, including drug-resistant strains. The patent encompasses compositions containing these compounds and outlines a process for their synthesis.
2. **Aryl derivatives and uses thereof** - Similar to his previous work, this patent also addresses antimalarial compounds and their efficacy against resistant strains of Plasmodium. It details compositions that leverage these compounds and includes methodologies for their preparation.
Career Highlights
Jacobus has had a fruitful career, having worked with notable pharmaceutical companies such as Jacobus Pharmaceutical Company, Inc. and Merck & Company, Inc. His tenure at these organizations has not only honed his skills as an inventor but has also allowed him to contribute to transformative medical advancements.
Collaborations
Throughout his career, Jacobus has collaborated with esteemed colleagues, including Norman P. Jensen and Guy Alan Schiehser. These partnerships have been instrumental in the development of innovative solutions for combating malaria and other health challenges.
Conclusion
David Penman Jacobus exemplifies the spirit of innovation through his dedicated work in pharmaceuticals. With a robust patent portfolio and numerous contributions to antimalarial research, he remains a pivotal figure in the ongoing battle against drug-resistant strains of malaria. His career serves as an inspiration for current and future inventors aiming to make a significant impact in the field of healthcare.